“HER2/neu expression status of post BCG recurrent non-muscle-invasive bladder urothelial carcinomas in relation to their primary ones”, Arch Ital Urol Androl, vol. 95, no. 2, May 2023, doi: 10.4081/aiua.2023.11313.